Skip to main content
FinSpry Logo
FinSpry
LXEO logo
LXEO
(NASDAQ)
Lexeo Therapeutics, Inc.
$4.71-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lexeo Therapeutics, Inc. (LXEO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Lexeo Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 4 professional research analysts

Consensus Rating

Buy
Based on 4 unique analysts
(5 total ratings in last 90 days)
Low Confidence∞:1 Buy/Sell

Average Price Target

$15.75
↑ 234.39% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest LXEO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Paul Matteis
Stifel Nicolaus
BuyMaintains
$17.00
Tessa Romero
JP Morgan
BuyMaintains
$12.00 → $9.00
Paul Matteis
Stifel Nicolaus
BuyMaintains
$17.00
Luca Issi
RBC Capital
BuyMaintains
$20.00
Geulah Livshits
Chardan Capital
BuyReiterates
$17.00

Frequently Asked Questions

What is the analyst consensus rating for LXEO?

The analyst consensus rating for LXEO is "Buy" based on 4 analyst recommendations.

What is the average price target for LXEO?

The average 12-month price target for LXEO is $15.75, representing an upside of 234.4% from the current price of $4.71.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.